Showing results (1141-1150 of 6,326) with videos related to

Sort By:
Pageof 633
Diabetes, Obesity & Metabolism|December 4, 2025
Relation of the stress hyperglycaemia ratio to residual risk in anticoagulated patients with atrial fibrillation: A report from the prospective Murcia AF Project III cohortEva Soler-Espejo, Yang Chen, José Miguel Rivera-Caravaca, et al.
Diabetes, Obesity & Metabolism|June 18, 2025
Oxidative stress, senescence and mRNA decay in peripheral blood mononuclear cells of women with gestational diabetes mellitus-link to increased cardiovascular disease riskTove Lekva, Marie Cecilie Paasche Roland, Elisabeth Qvigstad, et al.
Diabetes, Obesity & Metabolism|February 14, 2025
Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacyAnıl Cengiz, Calvin C Wu, Sean D Lawley
Diabetes, Obesity & Metabolism|February 14, 2025
Ketamine in insulin resistance: Pharmacokinetics, cardiovascular implications and cellular effects on cardiomyocytesAriana Ramirez, Stephanie Howes, Robert Chilton
Diabetes, Obesity & Metabolism|December 27, 2024
Ceramide-based risk score CERT-1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: A prospective cohort studyAlessandro Mantovani, Gianluigi Lunardi, Stefano Bonapace, et al.
Diabetes, Obesity & Metabolism|December 20, 2024
Evaluation of the efficacy and safety of controlled-release phentermine/topiramate in adults with obesity in Korea: A randomized, double-blind, placebo-controlled, phase 4 trial (QUEEN's study)Sangmo Hong, Won Jun Kim, Eun Seok Kang, et al.
Diabetes, Obesity & Metabolism|December 16, 2024
Metformin and risk of adverse pregnancy outcomes among pregnant women with gestational diabetes in the United Kingdom: A population-based cohort studyYa-Hui Yu, Robert W Platt, Pauline Reynier, et al.
Diabetes, Obesity & Metabolism|December 17, 2024
Precision medicine in type 1 diabetes: comparing metabolic outcomes of Control-IQ and MiniMed 780G according to patient characteristicsImene Gargouri, Hana Charfi, Wafa Belabed, et al.
Diabetes, Obesity & Metabolism|December 27, 2024
Efficacy of imeglimin treatment versus metformin dose escalation on glycemic control in subjects with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: A multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study)Akihiro Takahashi, Hiroshi Nomoto, Hiroki Yokoyama, et al.
Diabetes, Obesity & Metabolism|December 27, 2024
Anti-diabetic effects of GLP-1 receptor agonists on obese and overweight patients across diabetes status, administration routes, treatment duration and baseline characteristics: A systematic reviewHon Jen Wong, Norman H Y Lin, Yao Hao Teo, et al.
Pageof 633